3 Recruiting Cervical Cancer Phase 3 Clinical Trials

Active phase 3 studies for cervical cancer enrolling across the USA. Verify eligibility and contact site coordinators.

All Cervical Cancer studies

Phase 3 Studies for Cervical Cancer

🔵 Active, Not Recruiting Phase3

Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer

📍 Instituto do Câncer do Estado de São Paulo — São Paulo,

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3

A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

📍 USA Mitchell Cancer Institute-Clinical Trials ( Site 4126) — Mobile, Alabama

View Study & Checklist ➔

🟢 Recruiting Phase3

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

📍 Florida Cancer Specialists - South ( Site 7001) — Fort Myers, Florida

View Study & Checklist ➔